Serum level of soluble human leukocyte antigen-G molecules in non-Hodgkin lymphoma: Does it have a prognostic value?

Leukemia and Lymphoma

Volumn 49, Issue 8, 2008, Pages 1623-1626

  Yong, Park ^a   Kim, Seok Jin ^b   Lee, Seung Jin ^c   Kim, Byung Soo ^a  

^a Korea University Ansan Hospital   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; HLA G ANTIGEN; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; B CELL LYMPHOMA; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE FREE SURVIVAL; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLICULAR LYMPHOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSURVEILLANCE; LARGE CELL LYMPHOMA; LYMPHOMA CELL; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REFERENCE VALUE; TREATMENT OUTCOME;

HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 51349083329     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802129934     Document Type: Article

References (16)

1. Kirszenbaum, M., Djoulah, S., Hors, J., Prost, S., Dausset, J. and Carosella, E. D. (1999) Polymorphism of HLA-G gene and protein. J Reprod Immunol, 43, pp. 105-109.
2. Hammer, A., Hutter, H. and Dohr, G. (1997) HLA class I expression on the materno-fetal interface. Am J Reprod Immunol, 38, pp. 150-157.
3. Kovats, S., Main, E. K., Librach, C., Stubblebine, M., Fisher, S. J. and DeMars, R. (1990) A class I antigen, HLA-G, expressed in human trophoblasts. Science, 248, pp. 220-223.
4. Parham, P. (1995) Antigen presentation by class I major histocompatibility complex molecules: A context for thinking about HLA-G. Am J Reprod Immunol, 34, pp. 10-19.
5. Rouas-Freiss, N., Moreau, P., Ferrone, S. and Carosella, E. D. (2005) HLA-G proteins in cancer: Do they provide tumor cells with an escape mechanism?. Cancer Res, 65, pp. 10139-10144.
6. Wiendl, H., Mitsdoerffer, M., Hofmeister, V., Wischhusen, J., Weiss, E. H. Dichgans, J. et al. (2003) The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: Implications for myoblast transplantation and gene therapy. Brain, 126, pp. 176-185.
7. Le Friec, G, Laupeze, B., Fardel, O., Sebti, Y., Pangault, C. Guilloux, V. et al. (2003) Soluble HLA-G inhibits human dendritic cell-triggered allogeneic T-cell proliferation without altering dendritic differentiation and maturation processes. Human Immunol, 64, pp. 752-761.
8. Park, G. M., Lee, S., Park, B., Kim, E., Shin, J., Cho, K. and Ahn, K. (2004) Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis. Biochem Biophys Res Commun, 313, pp. 606-611.
9. Lefebvre, S., Antoine, M., Uzan, S., McMaster, M., Dausset, J. Carosella, E. D. et al. (2002) Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer. J Pathol, 196, pp. 266-274.
10. Paul, P., Rouas-Freiss, N., Khalil-Daher, I., Moreau, P., Riteau, B. Le Gal, F A et al. (1998) HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci USA, 95, pp. 4510-4515.
11. Ibrahim, E. C., Guerra, N., Lacombe, M. J., Angevin, E., Chouaib, S. Carosella, E. D. et al. (2001) Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma. Cancer Res, 61, pp. 6838-6845.
12. Sebti, Y., Le Friec, G, Pangault, C., Gros, F., Drenou, B. Guilloux, V. et al. (2003) Soluble HLA-G molecules are increased in lymphoproliferative disorders. Hum Immunol, 64, pp. 1093-1101.
13. Amiot, L., Le Friec, G, Sebti, Y., Drenou, B., Pangault, C. Guilloux, V. et al. (2003) HLA-G and lymphoproliferative disorders. Semin Cancer Biol, 13, pp. 379-385.
14. Gros, F., Sebti, Y., de Guibert, S., Branger, B., Bernard, M. Fauchet, R. et al. (2006) Soluble HLA-G molecules increase during acute leukemia, especially in subtypes affecting monocytic and lymphoid lineages. Neoplasia, 8, pp. 223-230.
15. Sebti, Y., Le Maux, A, Gros, F., De Guibert, S., Pangault, C. Rouas-Freiss, N. et al. (2007) Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders. Br J Haematol, 138, pp. 202-212.
16. Leleu, X., Le Friec, G, Facon, T., Amiot, L., Fauchet, R. Hennache, B. et al. (2005) Total soluble HLA class I and soluble HLA-G in multiple myeloma and monoclonal gammopathy of undetermined significance. Clin Cancer Res, 11, pp. 7297-7303.